Linda Tartaglione
Overview
Explore the profile of Linda Tartaglione including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Santo R, Niccolini B, Rizzi A, Bertini L, Pires Marafon D, Vaccaro M, et al.
Biosensors (Basel)
. 2024 Dec;
14(12).
PMID: 39727851
In physiological conditions, red blood cells (RBCs) demonstrate remarkable deformability, allowing them to undergo considerable deformation when passing through the microcirculation. However, this deformability is compromised in Type 1 diabetes...
2.
Pitocco D, Hatem D, Riente A, Giulio M, Rizzi A, Abeltino A, et al.
Diabetes Metab Res Rev
. 2024 Dec;
41(1):e70011.
PMID: 39627974
Aims: This review evaluates the mechanisms underlying red blood cell (RBC) membrane fluidity changes in diabetes mellitus (DM) and explores strategies to assess and address these alterations. Emphasis is placed...
3.
Mazzotta F, Lucaccini Paoli L, Rizzi A, Tartaglione L, Leo M, Popolla V, et al.
Nutr Diabetes
. 2024 Aug;
14(1):58.
PMID: 39095349
The development of advanced diabetes technology has permitted persons with type 1 diabetes mellitus to improve metabolic control significantly, particularly with the development of advanced hybrid closed-loop systems which have...
4.
Rizzi A, Tartaglione L, Lucaccini Paoli L, Leo M, Popolla V, Viti L, et al.
Diabetes Obes Metab
. 2024 Jul;
26(9):4078-4086.
PMID: 39010292
Aim: To assess the long-term glycaemic outcomes, with additional metrics, in adults with type 1 diabetes (T1D) using the Tandem t:slim X2 with Control-IQ technology advanced hybrid closed-loop (AHCL) system....
5.
Claro A, Palanza C, Mazza M, Rizzi A, Corsello A, Tartaglione L, et al.
World J Diabetes
. 2024 Jul;
15(6):1374-1380.
PMID: 38983820
Common psychiatric disorders (CPDs) and depression contribute significantly to the global epidemic of type 2 diabetes (T2D). We postulated a possible pathophysiological mechanism that through Bridge-Symptoms present in depression and...
6.
Tremamunno S, Tartaglione L, Telesca A, Rizzi A, Felici T, Mazzotta F, et al.
Endocrine
. 2024 Jan;
84(1):128-135.
PMID: 38197988
Aims: Both hyperglycaemia and large glycaemic variability are associated with worse outcomes in patients with Type 2 diabetes mellitus (T2DM), possibly causing sympatho-vagal imbalance and endothelial dysfunction. Continuous subcutaneous insulin...
7.
Pitocco D, Popolla V, Rizzi A, Lancellotti S, Tartaglione L, Sacco M, et al.
J Diabetes Complications
. 2023 Dec;
38(1):108653.
PMID: 38039934
Methods: In this prospective observational pilot study, we enrolled 35 T2DM subjects who underwent lower limb PTA. Transcutaneous oximetry was performed in all patients before and 6 weeks after PTA....
8.
Policola C, Di Stasio E, Rizzi A, Foca F, Tartaglione L, Locantore P, et al.
Diabetes Res Clin Pract
. 2023 Aug;
203:110882.
PMID: 37595845
Aim: To evaluate predisposition to eating disorders (ED) or body dissatisfaction in adults with type 1 diabetes mellitus (T1DM); to further investigate any differences in ED predisposition between subjects with...
9.
Gurgoglione F, Pitocco D, Montone R, Rinaldi R, Bonadonna R, Magnani G, et al.
J Clin Endocrinol Metab
. 2023 Jul;
109(1):237-244.
PMID: 37417706
Context: Coronary collateral (CC) vessel development appears to be protective with regard to adverse cardiovascular events and survival in patients with coronary chronic total occlusion (CTO). The influence of type...
10.
Tosti G, Barberio A, Tartaglione L, Rizzi A, Di Leo M, Viti L, et al.
Front Endocrinol (Lausanne)
. 2023 Jul;
14:1176623.
PMID: 37409227
During pregnancy, the complex hormonal changes lead to a progressive decrease of insulin sensitivity that can drive the onset of gestational diabetes (GDM) or worsen an already-known condition of insulin...